Diana F. Hausman

Sargramostim for Active Crohn's Disease

Joshua R. Korzenik, Brian K. Dieckgraefe, John F. Valentine et al. · New England Journal of Medicine · 2005 · 342 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Phase 1b Study of Pegylated Interferon Lambda 1 With or Without Ribavirin in Patients with Chronic Genotype 1 Hepatitis C Virus Infection†

Andrew J. Muir, Mitchell L. Shiffman, Atif Zaman et al. · Hepatology · 2010 · 246 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Phase I Study of Recombinant Interleukin-21 in Patients With Metastatic Melanoma and Renal Cell Carcinoma

John A. Thompson, Brendan D. Curti, Bruce G. Redman et al. · Journal of Clinical Oncology · 2008 · 186 citations

Medicine, Oncology, Pharmacology +17

A Multicenter Phase I Trial of PX-866, an Oral Irreversible Phosphatidylinositol 3-Kinase Inhibitor, in Patients with Advanced Solid Tumors

David S. Hong, Daniel W. Bowles, Gerald S. Falchook et al. · Clinical Cancer Research · 2012 · 175 citations

Medicine, Oncology, Pharmacology +15

A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins

Stephen B. Keysar, David P. Astling, Ryan T. Anderson et al. · Molecular Oncology · 2013 · 164 citations · Full text

Medicine, Oncology, Pharmacology +16